Wolfram Brugger
Impact in
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Immunology top 0.5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Hematology 77
- Hematopoietic Stem Cell Transplantation 37
- Acute Myeloid Leukemia Research 34
- Oncology 69
- CAR-T cell therapy research 16
- Co-authors
- Lothar Kanz (95 shared papers)Peter Brossart (29 shared papers)Robert Möhle (8 shared papers)Volker L. Reichardt (13 shared papers)Frank Grünebach (17 shared papers)Gernot Stuhler (12 shared papers)Hans‐Jörg Bühring (14 shared papers)Frank Bautz (5 shared papers)
- Journals
- Blood (62 papers)Annals of Oncology (13 papers)Journal of Clinical Oncology (7 papers)Experimental Hematology (6 papers)British Journal of Haematology (5 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Wolfram Brugger
188 papers receiving 12.1k citations
Wolfram Brugger's Hit Papers
Peers
Comparison fields: 5 of 123
- Hematology 2.4k
- Immunology 4.1k
- Genetics 2.0k
- Oncology 4.5k
- Pathology and Forensic Medicine 2.2k
Countries citing papers authored by Wolfram Brugger
This map shows the geographic impact of Wolfram Brugger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfram Brugger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfram Brugger more than expected).
Fields of papers citing papers by Wolfram Brugger
This network shows the impact of papers produced by Wolfram Brugger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfram Brugger. The network helps show where Wolfram Brugger may publish in the future.
Co-authors
The 25 scholars most cited alongside Wolfram Brugger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 195 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial Hit paper breakdown → | 2013 | 1179 |
| 2 | Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study Hit paper breakdown → | 2010 | 992 |
| 3 | Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival Hit paper breakdown → | 2012 | 680 |
| 4 | The Chemokine Receptor CXCR-4 Is Expressed on CD34+Hematopoietic Progenitors and Leukemic Cells and Mediates Transendothelial Migration Induced by Stromal Cell-Derived Factor-1 Hit paper breakdown → | 1998 | 558 |
| 5 | 2000 | 466 | |
| 6 | 2011 | 340 | |
| 7 | 1994 | 319 | |
| 8 | 1999 | 270 | |
| 9 | 1999 | 264 | |
| 10 | 2011 | 233 | |
| 11 | 2010 | 214 | |
| 12 | 2011 | 204 | |
| 13 | 2012 | 200 | |
| 14 | 1990 | 195 | |
| 15 | Heterogeneity among human bone marrow-derived mesenchymal stem cells and neural progenitor cells. | 2003 | 193 |
| 16 | 2006 | 193 | |
| 17 | 2010 | 190 | |
| 18 | The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes. | 2001 | 180 |
| 19 | 2002 | 179 | |
| 20 | Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes: a new approach to cancer immunotherapy. | 1990 | 177 |
About Wolfram Brugger
Wolfram Brugger is a scholar working on Hematology, Oncology, Immunology, Genetics and Pathology and Forensic Medicine, having authored 195 papers that have together received 12.6k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (37 papers), Immunotherapy and Immune Responses (36 papers), Acute Myeloid Leukemia Research (34 papers), Lymphoma Diagnosis and Treatment (31 papers), Chronic Lymphocytic Leukemia Research (17 papers), CAR-T cell therapy research (16 papers), Immune cells in cancer (13 papers) and Immune Cell Function and Interaction (13 papers). The work is most often cited by research in Hematology (2.4k citations), Immunology (4.1k citations), Genetics (2.0k citations), Oncology (4.5k citations) and Pathology and Forensic Medicine (2.2k citations). Wolfram Brugger has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Lothar Kanz, Peter Brossart, Robert Möhle, Volker L. Reichardt, Frank Grünebach, Gernot Stuhler, Hans‐Jörg Bühring, Frank Bautz, Stefan Wirths and Shahin Rafii. Their work appears in journals such as Blood, Annals of Oncology, Journal of Clinical Oncology, Experimental Hematology and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.